Core Viewpoint - The actual controller of Haohai Biological Technology, Jiang Wei, was penalized approximately 19.34 million yuan for insider trading and related activities, which the company claims will not significantly impact its operations or finances [2][4][6]. Group 1: Penalty Details - Jiang Wei was fined 1,463 million yuan and had 471 million yuan of illegal gains confiscated by the China Securities Regulatory Commission (CSRC) [4][6]. - The penalty is directed at Jiang Wei personally and is stated to be unrelated to the company's operations [6][7]. Group 2: Shareholding Structure - As of the end of the third quarter, Jiang Wei is the largest shareholder of Haohai Biological, holding 66.528 million shares, which accounts for 28.6% of the total shares [7][8]. - The top ten shareholders collectively hold 79.3% of the total shares, with Jiang Wei and You Jie being the main controllers of the company [8]. Group 3: Business Developments - Haohai Biological plans to invest 38.35 million yuan to acquire a 19.8% stake in Jiangxi Ruiji Biological Engineering Technology Co., Ltd., which specializes in the research, production, and sales of biological amniotic membranes [11][12]. - The investment aims to enhance the company's product portfolio and expand its business coverage in the ophthalmology and orthopedics sectors [11]. Group 4: Financial Performance of Target Company - Ruiji Biological reported a projected net profit of -12.74 million yuan for 2024, with a loss of 11.93 million yuan in the first three quarters of the current year [12][13]. - The transaction does not include performance commitments or guarantees, indicating potential risks for Haohai Biological if Ruiji's performance declines [13]. Group 5: Market Position - As of December 23, Haohai Biological's stock price was 44.25 yuan per share, with a total market capitalization of 10.292 billion yuan [14].

【导读】芦苇任中国邮政集团有限公司副总经理、党组成员 中国基金报记者 晨曦 芦苇履新，正式官宣！ 12 月 23 日，中国邮政官网显示，中国邮政集团有限公司领导人员调整。 公开信息显示，芦苇出生于 1971 年 10 月，持有中国、中国香港及澳大利亚注册会计师资 格，获澳大利亚迪肯大学会计学硕士学位。 | | | | | | | 控股公司及審議事业部。 | | 集团工会及直属单位。 | 各地部改。 | English | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 中国 明 段 | | 首页 关于我们 | 产品服务 | 新闻中心 | 党建时空 | 社会责任 | 企业文化 | 输入搜索关键字 | | 搜索 | | 新闻中心 | | | | | | | | | | | | iz | 时政要闻 | | 中国邮政集团有限公司领导人员调整 | | | | | | | | | | 集团要闻 | | | | | 2025-12-23 来源:中国邮政网 | | | | | | HI | 综合新闻 | | | | | 12月23日， ...

【导读】日本一正在报废施工的核反应堆发生含放射性水泄漏事件，可能有数人遭辐射 中国基金报记者 李智综合报道 12月23日消息，日本正在报废施工的核反应堆"普贤"发生含放射性水泄漏事件，可能有数人 遭辐射。 日本一正在报废施工的核反应堆 发生含放射性水泄漏事件 据央视新闻报道，当地时间12月23日，位于福井县敦贺市、正在进行报废施工的核反应 堆"普贤"发生含放射性水泄漏事件，可能有数人遭辐射。 据了解，在辅助厂房进行拆解作业期间，氚的浓度出现上升，目前尚未确认对外部环境造成 影响。 另据CCTV国际时讯报道，据日本原子能规制委员会消息，12月23日，位于福井县、正在进 行废炉作业的新型转换反应堆"普贤"在设施拆除过程中，发生了含有放射性物质氚的水泄漏 事件。 据规制委员会称，此次泄漏的水量约为20毫升，且水中放射性物质的浓度高。据称目前没有 发生作业人员因吸入水等导致的内部辐射暴露情况，但对于是否因水溅到身上等造成外部辐 射暴露，相关部门正在调查详细情况。 福岛第一核电站核污染水排放已超13万吨 当地时间12月22日，日本东京电力公司称，福岛第一核电站第17次核污染水排海工作当天结 束。 日方无视国际社会的强烈 ...

来源：国家发展改革委网站 近日，为深入贯彻党的二十大和二十届历次全会精神，落实《中华人民共和国学前教育法》要 求，更好促进学前教育普及普惠安全优质发展，有效降低人民群众保育教育成本，推动完善生 育支持政策体系，国家发展改革委、教育部、财政部联合印发《关于完善幼儿园收费政策的通 知》（发改价格〔2025〕1644号，以下简称《通知》）。 《通知》坚持学前教育的公益属性定位，通过规范收费项目、分类完善收费管理方式、明确收 费标准制定原则、健全收费政策评估优化机制、建立目录清单制度、加强收费行为监管等，促 进收费标准合理形成，更好发挥收费政策对优质普惠供给的牵引撬动作用。主要包括六方面内 容： 一是规范收费项目 ，明确幼儿园可以收取保育教育费、住宿费、提供托育服务的保育费、服 务性收费、代收费等五项收费。 二是分类完善收费管理方式 ，公办幼儿园、普惠性和其他非营利性民办幼儿园的保教费、住 宿费实行政府指导价，营利性民办幼儿园的保教费、住宿费及各类幼儿园的服务性收费和代收 费实行市场调节价，幼儿园开设托班收取的保育费参照保教费管理。 les & FR 点击下载中国基金报客户端 ■ 中国基金报内容矩阵 ■ 巅峰对话 投 ...

Core Viewpoint - The CAR-T cell therapy is a revolutionary cancer immunotherapy method, but its high cost (up to millions) limits accessibility for many patients. However, there is potential for significant cost reduction with universal CAR-T products, which could lower the price to around 10,000 yuan per injection, enhancing drug accessibility [2][3]. Group 1: Market and Competitive Landscape - The global CAR-T product landscape shows strong development in the US and China, with 7 and 8 products approved respectively. The US has a stronger commercial environment and payment capacity compared to China, which is improving [8]. - China is synchronized with international standards in blood cancer CAR-T development and has a lead in solid tumor CAR-T products, with no overseas products in critical clinical stages yet [8]. - China is at the forefront of universal CAR-T technology, while it ranks among the top globally in autologous CAR-T development [8]. Group 2: Product Development and Cost Reduction - The first NDA for a solid tumor CAR-T product, CT041, is expected to be approved in the first half of next year [10]. - The company is focusing on developing universal CAR-T products, which are anticipated to have a broader market space and lower production and management costs [12][13]. - The cost of universal CAR-T products could potentially drop to one-fiftieth of the current autologous CAR-T costs, estimated at around 10,000 yuan per injection [14]. Group 3: Future Outlook and Challenges - The first universal CAR-T product is projected to be launched before 2030, with a timeline of approximately four years for clinical trials and regulatory approvals [16][17]. - A significant challenge in developing universal CAR-T products is addressing rejection issues, which many companies face. The company has a unique platform that shows promising early clinical trial data [18]. Group 4: Commercialization Strategy - The company has achieved significant revenue growth with its first commercial product, with a 703.8% increase in revenue year-on-year [20]. - The company is building its own commercialization team, anticipating that its products will meet substantial clinical needs in the domestic market, especially for gastric cancer [22]. - The company plans to expand its market reach to Asia and eventually to Europe and the US, where there are no similar products available [24]. Group 5: Research and Development Focus - Future R&D investments will prioritize expanding indications for CT041 and accelerating the market entry of universal CAR-T products [25]. - The company aims to lower the cost of solid tumor CAR-T products to around 10,000 yuan while achieving efficacy comparable to autologous products, which is crucial for broader accessibility [25].

Core Viewpoint - The discussion highlights significant changes in asset allocation for insurance capital in 2026, emphasizing the importance of equity investments while maintaining fixed income allocations. There is a recommendation to lower risk appetite and focus on assets with higher certainty [2][10][36]. Asset Allocation Considerations for 2026 - The overall investment returns in the public market for 2026 are expected to be lower than in 2025, with equity markets transitioning to profit-driven phases [10]. - Fixed income investments are anticipated to provide stable coupon income, especially with the expected interest rate cuts in the U.S. during the first half of 2026 [10][12]. - The "Three Transformations" strategy (high dividend, alternative, and international) is suggested to address the current yield curve inversion in domestic markets [12]. - The focus on alternative investments, particularly in AI, new technologies, and biopharmaceuticals, is encouraged due to government support for new productive forces [10][12]. Fixed Income Investment Strategies - Fixed income remains a favorable investment choice for 2026, with a focus on both interest rates and credit risk [18]. - The credit risk in individual companies is rising, necessitating careful management to avoid potential losses [19]. - Cash investments, such as money market funds or high-grade short-duration funds, are favored for their safety and stable returns [19][20]. Stock Investment Changes for 2026 - The risk-reward ratio in equity markets has shifted, necessitating a focus on risk identification for long-term capital [22]. - The "barbell strategy" remains effective, balancing high dividend assets with technology stocks for alpha returns [22][24]. - The potential for structural opportunities in cyclical sectors and real estate is highlighted, especially if consumer policies improve [22][24]. Technology Investment Opportunities - Technology is identified as a critical long-term investment theme, with a focus on capturing growth in AI, semiconductors, and healthcare [30][32]. - The strategy includes both primary market investments and selective secondary market opportunities, emphasizing research-driven approaches [30][31]. - The importance of understanding the business models and cash flow of technology investments is stressed to avoid high-risk speculative assets [25][32].

来源：新华社 三、丰富群众精神文化生活。 开展"新春走基层"主题采访活动，唱响时代强音，激发奋 进力量。办好春节联欢等文艺演出活动，开展"欢欢喜喜过大年"主题活动、"非遗贺新春 ·寻味中国年"主题推广。开展"我们的中国梦——文化进万家"、文化科技卫生"三下 乡"等活动，面向基层提供优质文化产品。开展军民共建活动。丰富旅游产品，提升旅游 品质和旅游体验，推出系列消费惠民措施。加强跨部门执法协作，维护文化和旅游市场 秩序。 四、保障群众平安便捷出行。 加强客流动态研判，强化重点地区、热点线路、高峰时段 运力供给，统筹做好春运工作，最大限度满足群众出行需要。落实好重大节假日期间免 收小型客车通行费政策，强化道路疏堵保畅，提升充电、加油、用餐、如厕等服务质 量。加强务工流、学生流、旅游流等重点客流出行保障，严格落实军人、服现役和退出 现役的残疾军人、消防救援人员、烈士遗属等重点群体出行依法优先优待政策。优化完 善应急预案，有效应对恶劣天气、旅客滞留、险情事故等突发情况。深入开展高速公 路、桥梁隧道等基础设施风险隐患排查，严厉打击酒驾醉驾、"三超一疲劳"、非法营 运、农村"两违"等行为，确保出行安全。 五、狠抓安全生产 ...

Core Viewpoint - The Chinese government firmly opposes the U.S. decision to include DJI and other non-U.S. manufactured drones on a "regulated list," arguing that it unfairly targets Chinese companies and distorts the concept of national security [2] Group 1 - The Chinese Ministry of Foreign Affairs, represented by spokesperson Lin Jian, expressed strong opposition to the U.S. Federal Communications Commission's action [2] - The Chinese side calls for the U.S. to correct its erroneous practices and provide a fair, just, and non-discriminatory environment for Chinese enterprises [2]

Core Viewpoint - The article discusses the tragic passing of Vince Zampella, a legendary game producer and co-creator of the Call of Duty series, who died in a car accident at the age of 55, as confirmed by Electronic Arts (EA) [1][5]. Group 1: Accident Details - The accident occurred on December 21 at 12:45 PM on Angeles Crest Highway in the San Gabriel Mountains, where Zampella's 2026 Ferrari 296 GTS lost control and crashed into a concrete barrier, resulting in a fire that claimed the lives of both occupants [3][4]. - The specific cause of the accident has not yet been disclosed, and investigations are ongoing [4]. Group 2: Career Achievements - Vince Zampella was a prominent figure in the FPS gaming industry for over 20 years, having developed multiple billion-dollar game IPs and redefining modern shooting games [4]. - He was the chief designer for Medal of Honor: Allied Assault and co-founded Infinity Ward, which launched the first Call of Duty game in 2003, marking a significant shift in the gaming industry [4]. - In 2010, he founded Respawn Entertainment, which produced iconic games such as Titanfall, Apex Legends, and Star Wars Jedi [4]. - In 2021, Zampella was appointed as the head of the Battlefield series, leading to the successful return of Battlefield 6, which sold over 6.5 million copies in its first week [5]. Group 3: Industry Impact and Reactions - EA described Zampella's death as an "unimaginable loss," highlighting his profound influence on the video game industry [5][6]. - Respawn Entertainment and Infinity Ward expressed their condolences, recognizing Zampella as a giant in the industry whose legacy will be remembered beyond his games [5][7]. - Industry figures, including TGA producer Geoff Keighley, lamented the loss, noting that Zampella's greatest works were still ahead of him [5].

乌通社记者提问，目前，围绕结束俄乌战争的和平方案，相关谈判正在推进中。中国在这一 和平进程中扮演什么角色？第二个问题， 乌克兰总统泽连斯基表示，乌克兰即将通过一项新 的制裁方案，针对那些协助俄罗斯实施"侵略"行为的俄罗斯实体和个人，该制裁还将包括中 国公民。 外交部对此有何评论？ 林剑表示，乌克兰危机爆发以来，中方一直同包括俄乌在内的有关各方保持密切沟通，始终 致力于停火止战、劝和促谈，所做的努力国际社会有目共睹。中方支持一切有利于和平的努 力，将继续为此发挥建设性作用。 "关于你提到的第二个问题，中方一贯反对违反国际法、未经联合国安理会授权的单边制 裁。"林剑说， 我们敦促乌方立即纠正错误，中方将坚决维护中国企业和公民的正当合法权 益。 来源：北京日报客户端 12月23日，外交部发言人林剑主持例行记者会。 les & FR 点击下载中国基金报客户端 ■ 中国基金报内容矩阵 ■ 巅峰对话 投资热点说 ETF风向标 IPO情报站 fe o 1 ■ a a - 444 and 4 4 CHINAFUND CHINAFUND CHINAFUND CHINAFUND 开盘速递 港股日报 全球早班车 数说人物 √ � ...